je.st
news
Mark Carnegie-backed biotech Minomic creates improved prostate cancer test
2015-04-20 04:30:55| Biotech - Topix.net
Minomic CEO Brad Walsh says the company's new prostate cancer test could be on sale before the end of the year. Biotechnology company Minomic has developed a simpler, more accurate blood test for diagnosing prostate cancer, which could reduce the number of men who go onto invasive follow up tests and suffer plenty of heartache after receiving an initial 'false positive' result.
Tags: test
mark
improved
cancer
Category:Biotechnology and Pharmaceuticals